Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Randomized trial of lifestyle modification and pharmacotherapy for obesity.

Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, Hesson LA, Osei SY, Kaplan R, Stunkard AJ.

N Engl J Med. 2005 Nov 17;353(20):2111-20.

2.

Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial.

Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C.

Arch Intern Med. 2001 Jan 22;161(2):218-27.

PMID:
11176735
3.

Impact of weight loss on the metabolic syndrome.

Phelan S, Wadden TA, Berkowitz RI, Sarwer DB, Womble LG, Cato RK, Rothman R.

Int J Obes (Lond). 2007 Sep;31(9):1442-8. Epub 2007 Mar 13.

PMID:
17356528
4.

Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial.

Digenio AG, Mancuso JP, Gerber RA, Dvorak RV.

Ann Intern Med. 2009 Feb 17;150(4):255-62.

PMID:
19221377
5.

Combining behavioral and pharmacological treatments for obesity.

Phelan S, Wadden TA.

Obes Res. 2002 Jun;10(6):560-74. Review.

6.

Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.

Early JL, Apovian CM, Aronne LJ, Fernstrom MH, Frank A, Greenway FL, Heber D, Kushner RF, Cwik KM, Walch JK, Hewkin AC, Blakesley V.

Obesity (Silver Spring). 2007 Jun;15(6):1464-72.

7.

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.

Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E.

Am J Med. 1999 Feb;106(2):179-84.

PMID:
10230747
8.

Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.

Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Arnold ME, Steinberg CM.

Obes Res. 2000 Sep;8(6):431-7.

9.

Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.

Smith IG, Goulder MA; Sibutramine Clinical Study 1047 Team.

J Fam Pract. 2001 Jun;50(6):505-12.

PMID:
11407998
10.

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

Lindholm A, Bixo M, Björn I, Wölner-Hanssen P, Eliasson M, Larsson A, Johnson O, Poromaa IS.

Fertil Steril. 2008 May;89(5):1221-8. Epub 2007 Jul 2.

PMID:
17603048
11.
12.

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.

J Hum Hypertens. 2002 Jan;16(1):13-9.

13.

Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

Clin Ther. 2004 Sep;26(9):1427-35.

PMID:
15531005
14.

Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.

Barratt R, Frost G, O'Boyle A, Millward J, Truby H.

J Hum Nutr Diet. 2008 Jun;21(3):248-55. doi: 10.1111/j.1365-277X.2008.00870.x. Erratum in: J Hum Nutr Diet. 2008 Oct;21(5):525.

PMID:
18477180
15.

Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach.

Wadden TA, Berkowitz RI, Vogt RA, Steen SN, Stunkard AJ, Foster GD.

Obes Res. 1997 May;5(3):218-26.

16.

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.

McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K; Sibutramine in Hypertensives Clinical Study Group.

J Hum Hypertens. 2002 Jan;16(1):5-11.

17.

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.

Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.

Int J Obes (Lond). 2008 Apr;32(4):692-9. Epub 2007 Dec 11.

PMID:
18071341
18.

The obese older female patient: CV risk and the SCOUT study.

Coutinho WF.

Int J Obes (Lond). 2007 Nov;31 Suppl 2:S26-30; discussion S31-2.

PMID:
17968434
19.

Long-term pharmacotherapy for obesity.

Klein S.

Obes Res. 2004 Dec;12 Suppl:163S-6S. Review.

20.

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

Diabetes Obes Metab. 2000 Jun;2(3):175-87.

PMID:
11220553

Supplemental Content

Support Center